Шани Палух-Шимон

Научные публикации

• BRCA1/2 mutation carriers vs the general breast cancer population (N = 799,986): 21-gene assay-based molecular characterization
• International multidisciplinary consensus on the integration of radiotherapy with new systemic treatments for breast cancer: European Society for Radiotherapy and Oncology (ESTRO)-endorsed recommendations
• Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
• Pregnancy After Breast Cancer in Young BRCA Carriers: An International Hospital-Based Cohort Study
• Reply to the Letter to the Editor 'There is no place for ovarian cancer screening in hereditary breast-ovarian cancer syndromes (in regard to "ESMO Clinical Practice Guideline on risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes")' by W. Tjalma
• An urgent call for the immediate release of Israeli hostages
• Second breast cancer: recurrence score results, clinicopathologic characteristics, adjuvant treatments, and outcomes-exploratory analysis of the Clalit registry
• Clinical outcomes in estrogen receptor-positive early-stage breast cancer patients with Recurrence Score 26-30: observational real-world cohort study
• Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer
• Efficacy and safety results by menopausal status in monarchE: adjuvant abemaciclib combined with endocrine therapy in patients with HR+, HER2-, node-positive, high-risk early breast cancer
• Germline TP53 pathogenic variants and breast cancer: A narrative review
• Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline
• Current challenges and unmet needs in treating patients with human epidermal growth factor receptor 2-positive advanced breast cancer
• Divergence of mutational signatures in association with breast cancer subtype
• ESO-ESMO fifth international consensus guidelines for breast cancer in young women (BCY5)